StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Separately, Dawson James assumed coverage on shares of Tonix Pharmaceuticals in a research note on Wednesday, February 28th. They set a buy rating and a […] Read this story
